Associated Papers
Pachydermoperiostosis Associated With a Rare SLCO2A1 Mutation: A Case Report and Literature Review.
Mohammad M et al.
Cureus, 2025
Structure and transport mechanism of the human prostaglandin transporter SLCO2A1.
Xia Z et al.
Nature Communications, 2025
Primary hypertrophic osteoarthropathy: phenotypic variability and penetrance rate in heterozygotes for SLCO2A1 variants.
Arcanjo AM et al.
Jbmr Plus, 2025
A patient with pachydermoperiostosis harboring SLCO2A1 variants with a history of differentiating from acromegaly.
Nakano Y et al.
Bone Reports, 2023
Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study.
Hong HS et al.
Gut and Liver, 2022
Primary Hypertrophic Osteoarthropathy With Myelofibrosis.
Yousaf M et al.
Cureus, 2022
Functional analysis of mutant SLCO2A1 transporters found in patients with chronic enteropathy associated with SLCO2A1.
Seki S et al.
Journal of Gastroenterology and Hepatology, 2022
Four Variants of SLCO2A1 Identified in Three Chinese Patients with Chronic Enteropathy Associated with the SLCO2A1 Gene.
Huang H et al.
Digestive Diseases and Sciences, 2021
Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
Oiwa T et al.
The Journal of Dermatology, 2021
Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
Xu Y et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2021
Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action.
Nakanishi T et al.
Pharmacology & Therapeutics, 2021
The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners and Physiological/Pathophysiological Implications.
Sabirov RZ et al.
Life (basel, Switzerland), 2021
Chloride Channels in Astrocytes: Structure, Roles in Brain Homeostasis and Implications in Disease.
Elorza-Vidal X et al.
International Journal of Molecular Sciences, 2019
Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease.
Umeno J et al.
Journal of Gastroenterology, 2018
Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.
Nakanishi T et al.
The Aaps Journal, 2017
Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Guo T et al.
Molecular Medicine Reports, 2017
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter.
Umeno J et al.
Plos Genetics, 2015
Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
Diggle CP et al.
Human Mutation, 2012
Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.
Zhang Z et al.
American Journal of Human Genetics, 2012
Chronic Enteropathy Associated with SLCO2A1 Gene.
Umeno J et al.
Inflammatory Intestinal Diseases, 0